Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

NCT01586104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-10

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies intensity-modulated radiation therapy (IMRT) in treating younger patients with lung metastases. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

Conditions

  • Adult Rhabdomyosarcoma
  • Lung Metastases
  • Metastatic Ewing Sarcoma
  • Previously Treated Childhood Rhabdomyosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Wilms Tumor and Other Childhood Kidney Tumors
  • Stage IV Adult Soft Tissue Sarcoma
  • Stage IV Wilms Tumor
  • Stage V Wilms Tumor
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

RADIATION

intensity-modulated radiation therapy

Undergo cardiac-sparing whole lung IMRT

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Principal Investigators

  • David Walterhouse · Ann & Robert H Lurie Children's Hospital of Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
29 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2016-06-02
Completion
2016-06-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01586104 on ClinicalTrials.gov